Friday, July 10, 2026
🇺🇸 FDA

Intelligence · Clinical pipeline

Phase III Pipeline Programs

Late-stage pivotal and registrational clinical programs nearing regulatory submission.

Programs 5,427
Sponsors 1,771
Drugs 4,798

Quick answer

NovaPharmaNews tracks 5,427 phase iii pharmaceutical pipeline programs from ClinicalTrials.gov. Late-stage pivotal and registrational clinical programs nearing regulatory submission.

Top sponsors

Pipeline programs

Page 106 of 114

  1. bevacizumab

    Outlook Therapeutics NL B. V.

    Neovascular Age-related Macular Degeneration

    phase 3 mab completed

    1 trial

  2. bevacizumab

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Disease Free Survival

    phase 3 small molecule active

    1 trial

  3. bevacizumab

    Outlook Therapeutics NL B. V.

    Age-related Macular Degeneration

    phase 3 mab active

    4 trials

  4. bexarotene

    Eisai Co.,

    Non-small Cell Lung Cancer

    phase 3 small molecule completed

    1 trial

  5. bicyclol, 25mg/ tablet

    BRIGHT MINDS BIOSCIENCES INC.

    Drug-Induced Acute Liver Injury

    phase 3 small molecule active

    1 trial

  6. bimatoprost ophthalmic solution formulation A

    Allergan Pharmaceuticals International Limited

    Glaucoma

    phase 3 small molecule terminated

    1 trial

  7. bimekizumab

    Lacuna Pharma Pty Ltd

    Active juvenile idiopathic arthritis subtypes enthesitis-related arthritis (including juvenile-onset ankylosing spondylitis) and juvenile psoriatic arthritis

    phase 3 small molecule active

    1 trial

  8. bimekizumab

    Lacuna Pharma Pty Ltd

    Psoriatic Arthritis

    phase 3 small molecule active

    1 trial

  9. bimekizumab

    Lacuna Pharma Pty Ltd

    Hidradenitis Suppurativa

    phase 3 small molecule active

    1 trial

  10. bimekizumab

    Lacuna Pharma Pty Ltd

    Axial Spondyloarthritis

    phase 3 small molecule active

    1 trial

  11. bimekizumab

    Lacuna Pharma Pty Ltd

    Hidradenitis Suppurativa

    phase 3 small molecule active

    1 trial

  12. biphasic insulin aspart

    Novo Nordisk A/S

    Diabetes

    phase 3 small molecule completed

    1 trial

  13. blisibimod

    Santhera Pharmaceuticals (Deutschland) GmbH

    Systemic Lupus Erythematosus

    phase 3 small molecule completed

    1 trial

  14. bococizumab (PF-04950615)

    Pfizer

    Cardiovascular Disease

    phase 3 small molecule terminated

    1 trial

  15. botulinum toxin Type A

    Allergan Pharmaceuticals International Limited

    Pediatrics

    phase 3 mab completed

    4 trials

  16. brentuximab vedotin

    Takeda

    Hodgkin Lymphoma

    phase 3 small molecule completed

    3 trials

  17. brigatinib

    Takeda

    Non-Small Cell Lung Cancer

    phase 3 small molecule terminated

    2 trials

  18. budesonide/formoterol 'as needed' + budesonide placebo bid

    AstraZeneca

    Asthma

    phase 3 small molecule completed

    1 trial

  19. bupivacaine liposome injectable suspension

    Pacira Ireland Limited

    Knee Osteoarthritis

    phase 3 small molecule completed

    1 trial

  20. bupivacaine liposome injectable suspension

    Pacira Ireland Limited

    Pain

    phase 3 small molecule completed

    2 trials

  21. bupivacaine liposome injectable suspension

    Pacira Ireland Limited

    Pain, Postoperative

    phase 3 small molecule active

    1 trial

  22. cART(TDF/AZT+3TC+LPV/r)

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Acute HIV Infection

    phase 3 small molecule active

    1 trial

  23. canakinumab

    Novartis Pharmaceuticals

    Non-small Cell Lung Cancer

    phase 3 small molecule terminated

    2 trials

  24. candesartan

    Takeda

    Type 2 Diabetes

    phase 3 small molecule completed

    1 trial

  25. candesartan

    Takeda

    Type 1 Diabetes

    phase 3 small molecule completed

    1 trial

  26. candesartan cilexetil

    Takeda

    Type 1 Diabetes

    phase 3 small molecule completed

    1 trial

  27. casirivimab+imdevimab

    Regeneron UK Limited

    Immunocompromised

    phase 3 small molecule terminated

    1 trial

  28. casirivimab+imdevimab combination therapy

    Regeneron UK Limited

    COVID-19

    phase 3 small molecule terminated

    1 trial

  29. cemiplimab

    Regeneron UK Limited

    Non-small Cell Lung Cancer

    phase 3 small molecule active

    3 trials

  30. cetuximab + cisplatin + vinorelbine

    Merck KGaA, Darmstadt, Germany

    Non Small Cell Lung Cancer (NSCLC)

    phase 3 small molecule completed

    1 trial

  31. chemotherapy and SHR-1316(Adebrelimab) comnined with surgery or radiotherapy

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Limited Stage Small Cell Lung Cancer

    phase 3 other active

    1 trial

  32. ciclesonide

    Takeda

    Asthma

    phase 3 small molecule completed

    2 trials

  33. ciclesonide (XRP1526)

    Takeda

    Respiratory Tract Diseases

    phase 3 small molecule completed

    1 trial

  34. cilostazol

    Hospital Authority, Hong Kong

    Coronary Artery Stenosis

    phase 3 small molecule active

    1 trial

  35. cisplatin

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Oral Cavity

    phase 3 small molecule completed

    1 trial

  36. cisplatin

    Pari Pharma GmbH

    Lung Cancer

    phase 3 small molecule completed

    1 trial

  37. cisplatin

    United Therapeutics Europe Ltd

    Bladder Cancer

    phase 3 small molecule completed

    1 trial

  38. cisplatin i.p.

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Epithelial Carcinoma, Ovarian

    phase 3 small molecule active

    1 trial

  39. cleminorexton

    Centessa Pharmaceuticals plc

    Narcolepsy Type 1

    phase 3 small molecule active

    1 trial

  40. clopidogrel and aspirin

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Atherosclerosis

    phase 3 small molecule active

    1 trial

  41. cognitive-behavioral withdrawal regulation strategies

    BRIGHT MINDS BIOSCIENCES INC.

    Tobacco Dependence

    phase 3 other active

    1 trial

  42. colchicine

    Ultragenyx UK Limited

    Liver Cirrhosis, Biliary

    phase 3 small molecule completed

    1 trial

  43. conjugated estrogens

    Ultragenyx UK Limited

    Osteoporosis

    phase 3 small molecule completed

    1 trial

  44. copolymer 1

    Ultragenyx UK Limited

    Multiple Sclerosis

    phase 3 small molecule completed

    1 trial

  45. cpFT

    Pari Pharma GmbH

    Infertility

    phase 3 small molecule active

    1 trial

  46. custirsen sodium

    Teva Pharma GmbH

    Castrate-Resistant Prostate Cancer

    phase 3 small molecule terminated

    1 trial

  47. cyclobenzaprine hydrochloride

    Teva Pharma GmbH

    Chronic Migraine

    phase 3 small molecule terminated

    1 trial

  48. cyclophosphamide

    Partner Therapeutics Limited

    Breast Cancer

    phase 3 small molecule completed

    1 trial

Frequently asked questions

How many Phase III pipeline programs are in the directory?

5,427 published programs match this development stage in our ClinicalTrials.gov index.

What defines this pipeline stage?

Phase and status reflect ClinicalTrials.gov registry fields at last sync. See our clinical trial phases reference for methodology.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.